Pharmacokinetics of [14C]Omeprazole in Patients with Liver Cirrhosis
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (1) , 71-78
- https://doi.org/10.2165/00003088-199324010-00006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetic Study of Omeprazole in Elderly Healthy VolunteersClinical Pharmacokinetics, 1992
- Pharmacokinetics of various single intravenous and oral doses of omeprazoleEuropean Journal of Clinical Pharmacology, 1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric UlcerNew England Journal of Medicine, 1989
- Healing and relapse of severe peptic esophagitis after treatment with omeprazoleGastroenterology, 1988
- Biliary excretion of intravenous [14C] omeprazole in humansClinical Pharmacology & Therapeutics, 1987
- DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITISThe Lancet, 1987
- A Comparison of Two Different Doses of Omeprazole Versus Ranitidine in Treatment of Duodenal UlcersJournal of Clinical Gastroenterology, 1986
- The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazoleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut, 1983